FAIRFAX FINANCIAL HOLDINGS LTD/ CAN Annual Report - Investor Summary

Unpack Fairfax Financial Holdings' latest annual report. This investor summary highlights key insights, helping retail investors understand the company's performance, financial health, and future prospects at a glance.

Our Take on Fairfax Financial Holdings LTD/ CAN:

Here's what we've gathered from the report:

1. Business Overview (what the company does) Fairfax Financial Holdings operates as a highly diversified holding company, built on two core pillars: property and casualty insurance and reinsurance and a broad portfolio of non-insurance businesses.

   Insurance Operations: Fairfax's global insurance footprint includes major North American players like Zenith National, Northbridge Financial, and Crum & Forster. Internationally, they operate through Gulf Insurance Group and Bryte Insurance, alongside global reinsurers such as Odyssey Group, Brit Group, and Allied World. The company also manages a life insurance and run-off segment.

   Non-Insurance Businesses: Beyond insurance, Fairfax holds significant stakes in diverse sectors. These include restaurants and retail (e.g., Recipe Unlimited Corporation, Sporting Life Group, Sleep Country Canada), real estate, and various other ventures (e.g., Peak Achievement Athletics, Dexterra Integrated Facilities Management, AGT Food And Ingredients, Thomas Cook India). Their investment management arm, Hamblin Watsa Investment Counsel, actively manages their substantial investment portfolio. This extensive diversification spans multiple sectors and geographies, including Asia, Latin America, and Central and Eastern Europe.

   How they performed this year: Fairfax achieved a strong overall profit, primarily driven by exceptional returns from its investment portfolio. Total profit surged by 24% to $5.28 billion. However, the core insurance underwriting business, measured by the "insurance service result," faced challenges, declining by 13.6% compared to the previous year. This indicates that while investments provided a significant boost, their primary insurance operations experienced profitability headwinds.

2. Financial Performance (revenue, profit, year-over-year changes) Let's examine Fairfax's key financial figures for the year ending December 31, 2025, compared to 2024:

   • Total Revenue:
     • Insurance Revenue: Grew modestly by 1.7% to $31.60 billion in 2025 from $31.06 billion in 2024.
     • Non-Insurance Revenue: Jumped robustly by 27.8% to $8.54 billion in 2025 from $6.68 billion in 2024, highlighting strong performance in these diverse segments.
   • Investment Income: This was a standout area.
     • Net Gains on Investments: Skyrocketed to $3.15 billion in 2025, a massive increase from $1.07 billion in 2024. This nearly tripled, primarily driving overall profit growth.
     • Total Investment Income: Overall investment income grew over 44%, reaching $6.54 billion in 2025 compared to $4.54 billion in 2024.
   • Profit (Net Earnings):
     • Fairfax's total net profit reached $5.28 billion in 2025, a healthy 24% increase from $4.26 billion in 2024.
     • Profit attributable to Fairfax shareholders: This key investor metric rose to $4.77 billion in 2025, up 23% from $3.87 billion in 2024.
   • Earnings Per Share (EPS):
     • Net Earnings Per Share: Jumped significantly to $230.07 in 2025, a substantial 32.7% increase from $173.41 in 2024. This higher growth rate, compared to total profit, partly reflects a reduction in outstanding shares.
     • Shares Outstanding: The average number of shares decreased from 22.37 million in 2024 to 21.45 million in 2025, boosting EPS for shareholders.
   • Dividends: The company maintained its cash dividend at $15.00 per share for both 2025 and 2024.

3. Management Discussion (MD&A highlights) Fairfax strategically managed its portfolio through acquisitions and divestments. The company expanded its insurance footprint by acquiring Erb Asfalistiki and Eurolife FFH General Insurance Single Member S.a. in October 2025, and Albingia in May 2025. Conversely, Fairfax disposed of Meadow Foods Holdings Limited in November 2024, reflecting a continuous re-evaluation of its diverse holdings.

   Major Wins:

   • Exceptional Investment Performance: The nearly threefold increase in "net gains on investments" to $3.15 billion was the most significant win, propelling overall profitability.
   • Strong Non-Insurance Business Growth: A nearly 28% increase in non-insurance revenue demonstrates healthy performance and diversification benefits.
   • Share Buybacks: The reduction in outstanding shares enhanced Earnings Per Share, directly benefiting shareholders.

   Challenges:

   • Declining Insurance Underwriting Profitability: The core insurance business's "insurance service result" (profit from underwriting policies) dropped by 13.6% to $3.85 billion. This suggests increased claims costs, competitive pricing pressures, or other factors impacting the profitability of their insurance policies, despite revenue growth.
   • Higher Finance Expenses from Insurance Contracts: A significant increase in "net finance expense from insurance contracts" from $1.75 billion to $2.45 billion indicates higher costs associated with managing insurance liabilities, further impacting the insurance segment's profitability.
   • Assets Held for Sale: The balance sheet shows a new, substantial entry of $3.45 billion in "assets held for sale," along with $3.64 billion in associated liabilities. While this could be a strategic move to streamline operations or raise capital, it introduces uncertainty regarding which assets are being divested, the reasons for their sale, and the potential impact on future revenue and profit streams.

   Leadership and Strategy Changes: Fairfax actively optimizes its portfolio. Acquisitions of Erb Asfalistiki, Eurolife FFH General Insurance, and Albingia signal a strategic expansion within its insurance operations, particularly in specific geographic markets. The disposal of Meadow Foods Holdings Limited, conversely, indicates a continuous refinement of its non-insurance portfolio. Furthermore, a significant reduction in preferred stock represents a strategic move to optimize the capital structure, likely aiming for greater financial flexibility and reduced fixed obligations. The presence of "assets held for sale" further underscores an ongoing strategic review and potential restructuring of its holdings.

4. Financial Health (debt, cash, liquidity) Fairfax maintains a solid financial position, marked by growing assets and equity, alongside increased debt.

   • Total Assets: The company's total assets grew significantly by 11.4% to $107.79 billion in 2025 from $96.78 billion in 2024.
   • Cash and Investments: Fairfax holds substantial liquid assets. "Holding company cash and investments" increased to $2.72 billion (from $2.50 billion), and "subsidiary cash and short-term investments" grew to $8.98 billion (from $7.62 billion), providing ample liquidity.
   • Total Equity: Shareholder value increased, with total equity growing by 8.9% to $30.87 billion in 2025 from $28.35 billion in 2024, signaling financial strength.
   • Common Shareholders' Equity: Common shareholders' equity rose by 14.5% to $26.28 billion in 2025 from $22.96 billion in 2024.
   • Preferred Stock: Fairfax significantly reduced preferred stock from $1.11 billion in 2024 to $231.7 million in 2025, simplifying its capital structure and reducing fixed dividend obligations.
   • Debt (Borrowings): Total borrowings increased to $13.64 billion in 2025 from $11.75 billion in 2024. Although debt grew, rising equity kept the debt-to-equity ratio relatively stable (approximately 0.44 in 2025 vs. 0.41 in 2024).
   • Insurance Contract Liabilities: As an insurer, Fairfax's "insurance contract liabilities," representing future claim payouts, increased to $50.44 billion in 2025 from $47.60 billion in 2024. This is a normal part of insurance business growth but represents a significant long-term obligation.
   • Derivative Obligations: These obligations, often used for hedging market risks, more than doubled to $786.9 million in 2025 from $356.9 million in 2024. While potentially part of a risk management strategy, this increase warrants attention due to derivatives' inherent complexity and potential volatility.
   • Internal Controls: Management confirmed effective internal controls over financial reporting as of December 31, 2025, enhancing confidence in the reliability of its financial statements.

5. Risk Factors (key risks)

   • Complexity and Volatility of Insurance Liabilities: Independent auditors (PwC) identified the "measurement of the liability and asset for incurred claims" as a "critical audit matter." This highlights the significant judgment and assumptions involved in estimating future insurance claims. Inaccurate estimates could lead to future reserve strengthening, negatively impacting profitability.
   • Reliance on Investment Gains: While a major strength this year, investment gains are inherently volatile and subject to market fluctuations. A downturn in financial markets could severely impact overall profitability, especially given the decline in core insurance underwriting results this year.
   • Increased Debt and Interest Rate Risk: Rising total borrowings increase interest expenses. If interest rates continue to climb, the cost of servicing this debt could further erode profits.
   • Derivative Risks: The significant increase in derivative obligations, while potentially for hedging, introduces market, counterparty, and operational risks. Poor management or adverse market movements could lead to substantial losses.
   • Uncertainty from Strategic Divestments: The substantial "assets held for sale" introduce uncertainty. The reasons for these sales, divestment terms, and their ultimate impact on the company's strategic focus, revenue, and future cash flows are not yet clear and could affect investor sentiment.
   • Catastrophic Events and Economic Downturns: As an insurer, Fairfax faces exposure to large-scale natural disasters and other catastrophic events. A severe economic downturn could also impact investment returns, claims frequency, and its non-insurance businesses' performance.